US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Human Papilloma Virus Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... in human papilloma virus partnering deals Top human papilloma virus deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Human Papilloma Virus Partnering 2009-2014 provides understanding and access ...  |  read more...
USD 995
Diabetes Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors diabetes technology. These deals tend to be multicomponent, starting with collaborative ...  |  read more...
USD 995
Liver Disease Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... liver disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors liver disease technology. These deals tend to be ...  |  read more...
USD 695
Prenatal Screening Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top prenatal screening deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Prenatal Screening Partnering 2009-2014 provides understanding and access to the prenatal screening partnering deals ...  |  read more...
USD 695
Sleep Disorders Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of sleep disorders partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors depression technology. These deals tend to be ...  |  read more...
USD 695
Depression Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors depression technology. These deals tend to be multicomponent, starting with collaborative ...  |  read more...
USD 695
Alzheimer's Disease Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of alzheimer’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors alzheimer’s disease technology. These deals tend to ...  |  read more...
USD 1,795
Attention Deficit Hyperactivity Disorder Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... report provides an analysis of attention deficit disorder partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors attention deficit ...  |  read more...
USD 695
Dementia Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dementia technology. These deals tend to be multicomponent, starting with collaborative ...  |  read more...
USD 695
Learning Disability Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top learning disability deals by value Deals listed by company A-Z, industry sector, stage of development, technology type This report provides details of the latest learning disability agreements announced in the healthcare sectors, ...  |  read more...
USD 695
Drug Addiction Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals Top drugs deal addiction by value Deals listed by company A-Z, industry sector, stage of development, technology type Drug Addiction Partnering 2009-2014 provides understanding and access to the drug addiction partnering deals and agreements ...  |  read more...
USD 695
Allergic Rhinitis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top allergic rhinitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Allergic Rhinitis Partnering 2009-2014 provides understanding and access to the allergic rhinitis partnering deals ...  |  read more...
USD 695
Asthma Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Asthma Partnering 2009-2014 provides understanding and access to the asthma partnering deals and agreements entered into by the worlds ...  |  read more...
USD 995
Pneumonia Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pneumonia Partnering 2009-2014 provides understanding and access to the pneumonia partnering deals and agreements entered into by the worlds ...  |  read more...
USD 695
Sexual Dysfunction Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top sexual dysfunction deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sexual Dysfunction Partnering 2009-2014 provides understanding and access to the sexual dysfunction partnering deals ...  |  read more...
USD 695
Clinical Research (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 110 largest Clinical Research (UK) companies. The Clinical Research (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Angion Biomedica Corp. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Angion Biomedica Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Connexios Life Sciences Pvt. Ltd. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... Pvt. Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Connexios Life Sciences Pvt. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
USD 1,500
Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Tetraphase Pharmaceuticals Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
TauRx Therapeutics Ltd. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of TauRx Therapeutics Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
uniQure NV - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of uniQure BV’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
ORCA Therapeutics B.V. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ORCA Therapeutics B.V.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Zedira GmbH - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Zedira GmbH’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ascepion Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Sagami Rubber Industries Co., Ltd. - Company Capsule
11/10/2014 | published by: Canadean Ltd
... company overview, key facts, major products and services, financial ratios, financial analysis, key employees, company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to access key information ...  |  read more...
USD 99
1  2  3    5    7  8  9  10